Gastrointestinal release capsule for use in a method for desensitising and/or inducing tolerance in a patient with a peanut allergy
US11185567B2 · kind B2 · utility
0Cited by
1References
26Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 9, 2018 |
| Grant date | Nov 30, 2021 |
| Priority date | — |
| Expiry date | Mar 12, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/577
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Gastro-intestinal release capsule intended for oral use in a method for desensitizing and/or inducing tolerance in a peanut-allergic subject or, alternatively, for diagnosing a peanut allergy in a subject. The capsule has a shell and a core, the core has a composition of peanut including peanut, at least one oil, at least one first pulverulent excipient and, optionally, at least one second prebiotic excipient. The capsule is provided and ingested in an unopened form.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.